In April of 2018, the Indianapolis-based life sciences startup Drug Free Therapeutix (DFTx) was named a winner of the 7th annual M2D2 $200K Challenge. Their innovation: a universal neurostimulation dosing system for pain management. The 2020 Challenge is coming up in March, and because we’re always interested in the progress of past winners, we reached out to DFTx CEO Stephen Hourigan to get an update.Continue reading
Last April, San Francisco-based startup Respirix was named a first-place winner at the 8th annual M2D2 $200K Challenge. Led by CEO Eric Kriegstein, Respirix won the first Boston Scientific Award for their non-invasive cardiac monitor for congestive heart failure patients. With the 2020 Challenge right around the corner, we checked in with Eric to see what’s happened at Respirix over the last year.Continue reading
For the second year, the Deshpande Foundation has announced it will sponsor up to three early-stage India-based life sciences companies that are chosen as finalists in the M2D2 $200K Challenge. This generous sponsorship will cover all travel and housing expenses for those teams, as well as tours around the Massachusetts life sciences innovation ecosystem and introductions to potential mentors and investors.Continue reading
The $200K Challenge is back for its ninth consecutive year! Hosted by M2D2, this event focuses on identifying and rewarding disruptive companies in the medical technology and biotechnology industries. We want to see your innovations brought to life.
Every year we receive scores of entries (nearly 150 in 2019) from life sciences entrepreneurs worldwide. India, China, and Australia are just a few of the many countries involved in the 2019 200K Challenge. Last year, our judges selected 12 winners—a Challenge record!Continue reading